首页> 外文期刊>Clinical therapeutics >The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China.
【24h】

The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China.

机译:中医随机对照试验报道的质量:对来自中国大陆的13种随机选择期刊的调查。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: The number of randomized controlled trials (RCTs) of traditional Chinese medicine (TCM) is increasing. However, there have been few systematic assessments of the quality of reporting of these trials. Objective: This study was undertaken to evaluate the quality of reporting of RCTs in TCM journals published in mainland China from 1999 to 2004. METHODS: Thirteen TCM journals were randomly selected by stratified sampling of the approximately 100 TCM journals published in mainland China. All issues of the selected journals published from 1999 to 2004 were hand-searched according to guidelines from the Cochrane Centre. All reviewers underwent training in the evaluation of RCTs at the Chinese Centre of Evidence-based Medicine. A comprehensive quality assessment of each RCT was completed using a modified version of the Consolidated Standards of Reporting Trials (CONSORT) checklist (total of 30 items) and the Jadad scale. Disagreements were resolved by consensus. RESULTS: Seven thousand four hundred twenty-two RCTs were identified. The proportion of published RCTs relative to all types of published clinical trials increased significantly over the period studied, from 18.6% in 1999 to 35.9% in 2004 (P < 0.001). The mean (SD) Jadad score was 1.03 (0.61) overall. One RCT had a Jadad score of 5 points; 14 had a score of 4 points; and 102 had a score of 3 points. The mean (SD) Jadad score was 0.85 (0.53) in 1999 (746 RCTs) and 1.20 (0.62) in 2004 (1634 RCTs). Across all trials, 39.4% of the items on the modified CONSORT checklist were reported, which was equivalent to 11.82 (5.78) of the 30 items. Some important methodologic components of RCTs were incompletely reported, such as sample-size calculation (reported in 1.1% of RCTs), randomization sequence (7.9%), allocation concealment (0.3 %), implementation of the random-allocation sequence (0%), and analysis of intention to treat (0%). CONCLUSION: The findings of this study indicate that the quality of reporting of RCTs of TCM has improved, but remains poor.
机译:背景:中药(TCM)的随机对照试验(RCT)的数量正在增加。但是,很少有系统评估这些试验的报告质量。目的:本研究旨在评估1999年至2004年在中国大陆出版的中医期刊中RCT报道的质量。方法:通过分层抽样从中国大陆出版的约100种中医期刊中随机抽取13种中医期刊。根据Cochrane中心的指南,对1999年至2004年出版的部分期刊的所有期刊进行了手工搜索。所有审阅者均在中国循证医学中心接受了RCT评估培训。使用修订的《报告试验综合标准》(CONSORT)清单(共30项)和Jadad量表对每个RCT进行了全面的质量评估。分歧通过协商解决。结果:确定了7422个RCT。相对于所有类型的已发表临床试验,已发表的RCT的比例在研究期间显着增加,从1999年的18.6%增加到2004年的35.9%(P <0.001)。总体Jadad评分平均为1.03(0.61)。一名RCT的贾达德分数为5分; 14分得4分; 102分得3分。 1999年(746个RCT)的平均(SD)Jadad评分为0.85(0.53),2004年(1634个RCT)的平均值(SD)为1.20(0.62)。在所有试验中,修改后的CONSORT清单上报告了39.4%的项目,相当于30个项目中的11.82(5.78)。 RCT的一些重要方法学组成部分未得到完整报告,例如样本量计算(报告为RCT的1.1%),随机化序列(7.9%),分配隐藏(0.3%),随机分配序列的执行(0%)。 ,以及治疗意向分析(0%)。结论:本研究结果表明,中医RCT的报告质量有所提高,但仍然很差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号